Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?

Published in Eye for Pharma 10 November by Marc Yates

Inizio

- PMLiVE

IMI picks Ipsen’s Marc de Garidel to chair governing board

He takes over from former UCB CEO Roch Doliveux

It’s time to get diabetes right

Patients should have access to the right treatment and care, at the right time, says the ABPI Pharmaceutical Diabetes Initiative 

Webinar: The storytelling method that works for e-detailing

If you can involve healthcare professionals in a story, they will be more open to your arguments.

Anthill Agency

- PMLiVE

Icelandic genome study yields new disease genes

Nature Medicine study focuses on the probability of developing Alzheimer’s

- PMLiVE

Leo Pharma sets out its social media principles

Also expands its use of Twitter with two newaccounts

- PMLiVE

Merck KGaA ‘to promote’ Stefan Oschmann to chief executive

Germanphamra company reportedly set to elevate him to the top job next year

- PMLiVE

Takeda’s once-weekly DPP-4 inhibitor cleared in first market

Zafatek’s authorisation one of a flurry of new approvals for a number of firms in Japan

- PMLiVE

WHO: Medicine costs ‘too high’ for European governments

New report shows transparency and co-operation needed to help reduce drug prices

- PMLiVE

Final NICE ‘no’ for Celgene’s Imnovid

England’s pricing watchdog says multiple myeloma drug is just too expensive for the NHS

Teva appoints Timothy Wright as business development head

The former Covidien Pharma president mostrecently led a US cancer centre

- PMLiVE

AZ links with Harvard for diabetes research

Firm extends ties with the highly respected academic institution in hope of finding innovative leads

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links